Prophylactic Cranial Irradiation for Patients with Surgically Resected Small Cell Lung Cancer Jianlin Xu, MD, Haitang Yang, MD, Xiaolong Fu, MD, Bo Jin, MD, Yuqing Lou, MD, Yanwei Zhang, PhD, Xueyan Zhang, PhD, Hua Zhong, PhD, Huimin Wang, MD, Dan Wu, MD, Baohui Han, MD, PhD Journal of Thoracic Oncology Volume 12, Issue 2, Pages 347-353 (February 2017) DOI: 10.1016/j.jtho.2016.09.133 Copyright © 2016 International Association for the Study of Lung Cancer Terms and Conditions
Figure 1 Flow diagram of patients studied. PCI, prophylactic cranial irradiation; PET, positron emission tomography. Journal of Thoracic Oncology 2017 12, 347-353DOI: (10.1016/j.jtho.2016.09.133) Copyright © 2016 International Association for the Study of Lung Cancer Terms and Conditions
Figure 2 Kaplan-Meier survival curves for overall survival analysis between the prophylactic cranial irradiation (PCI) and non-PCI cohorts. Overall survival comparison between PCI and non-PCI cohorts in all patients (A), p-Stage-I (B), p-Stage-II (C), and p-Stage-III patients (D). HR, hazard ratio; CI, confidence interval. Journal of Thoracic Oncology 2017 12, 347-353DOI: (10.1016/j.jtho.2016.09.133) Copyright © 2016 International Association for the Study of Lung Cancer Terms and Conditions
Figure 3 Cumulative incidence of brain metastases in the prophylactic cranial ir (PCI) and non-PCI cohorts. The cumulative occurrence of brain metastasis in all patients (A), p-Stage-I (B), p-Stage-II (C), and p-Stage-III patients (D). Journal of Thoracic Oncology 2017 12, 347-353DOI: (10.1016/j.jtho.2016.09.133) Copyright © 2016 International Association for the Study of Lung Cancer Terms and Conditions